113
Views
2
CrossRef citations to date
0
Altmetric
Original Research

MAOB rs3027452 Modifies Mood Improvement After Tryptophan Supplementation

ORCID Icon, , , &
Pages 1751-1756 | Published online: 06 May 2021

References

  • Young VR, Hussein MA, Murray E, Scrimshaw NS. Plasma tryptophan response curve and its relation to tryptophan requirements in young adult men. J Nutr. 1971;101:45–59. doi:10.1093/jn/101.1.45
  • Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. l-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int J Tryptophan Res. 2009;2:45–60. doi:10.4137/IJTR.S2129
  • McCorvy JD, Roth BL. Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther. 2015;150:129–142. doi:10.1016/j.pharmthera.2015.01.009
  • Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49:124–138. doi:10.1177/070674370404900208
  • Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29:459–525. doi:10.1177/0269881115581093
  • Morrissette DA, Stahl SM. Modulating the serotonin system in the treatment of major depressive disorder. CNS Spectrums. 2014;19(S1):57–68. doi:10.1017/S1092852914000613
  • Mulinari S. Monoamine theories of depression: historical impact on biomedical research. J Hist Neurosci. 2012;21:366–392. doi:10.1080/0964704X.2011.623917
  • Hindmarch I. Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur Psychiatry. 2002;17:294–299. doi:10.1016/S0924-9338(02)00653-3
  • Melander H, Salmonson T, Abadie E, van Zwieten-boot B. A regulatory apologia—A review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. Eur Neuropsychopharmacol. 2008;18:623–627. doi:10.1016/j.euroneuro.2008.06.003
  • Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002;287:1840–1847. doi:10.1001/jama.287.14.1840
  • Owens MJ. Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond. J Clin Psychiatry. 2004;65:5–10.
  • Lauer JW. Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; the clinical aspects. J Clin Exp Psychopathol. 1958;19:110–113.
  • Coppen A, Shaw DM, Farrell JP. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet. 1963;7272:79–81. doi:10.1016/S0140-6736(63)91084-5
  • Glassman AH, Platman SR. Potentiation of a monoamine oxidase inhibitor by tryptophan. J Psychiatr Res. 1969;7:83–88. doi:10.1016/0022-3956(69)90013-2
  • Pare CM. Potentiation of monoamino oxidase inhibitors by tryptophan. Lancet. 1963;7(2):527–528. doi:10.1016/S0140-6736(63)90271-X
  • Chouinard G. Bupropion and amitriptyline in the treatment of depressed patients. J Clin Psychiatry. 1983;44:121–129.
  • Markus CR. Dietary amino acids and brain serotonin function; implications for stress-related affective changes. Neuromolecular Med. 2008;10:247–258. doi:10.1007/s12017-008-8039-9
  • Markus R, Panhuysen G, Tuiten A, Koppeschaar H. Effects of food on cortisol and mood in vulnerable subjects under controllable and uncontrollable stress. Physiol Behav. 2000;70:333–342. doi:10.1016/S0031-9384(00)00265-1
  • Andrade‐Fernandez EM, Arce‐Fernandez C, Seaone‐Pesqueira G. Adaptación al español del cuestionario «Perfil de los Estados de Ánimo» en una muestra de deportistas. Psicothema. 2000;214:708–713.
  • Goldberg LR. Differential attribution to trait‐descriptive terms to oneself as compared to well‐liked, neutral and disliked others: a psychometric analysis. J Pers Soc Psychol. 1978;26:1012–1028. doi:10.1037/0022-3514.36.9.1012
  • Fernstrom JD. A perspective on the safety of supplemental tryptophan based on its metabolic fates. J Nutr. 2016;146:2601S–2608S. doi:10.3945/jn.115.228643
  • Jenkins TA, Nguyen JCD, Polglaze KE, et al. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8:56. doi:10.3390/nu8010056
  • Young SN, Teff KL. Tryptophan availability, 5HT synthesis and 5HT function. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13:373. doi:10.1016/0278-5846(89)90126-7
  • Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J Neural Transm. 2000;107:523–530. doi:10.1007/s007020070075
  • Jansson M, McCarthy S, Sullivan PF, et al. MAOA haplotypes associated with thrombocyte-MAO activity. BMC Genet. 2005;6:46. doi:10.1186/1471-2156-6-46
  • Gibson EL. Tryptophan supplementation and serotonin function: genetic variations in behavioural effects. Proc Nutr Soc. 2018;77:174–188. doi:10.1017/S0029665117004451